Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe
- Written by PR Newswire
![]() |
BENGALURU, India, Dec. 1, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris' biosimilars business in 31 European countries has been successfully completed.
Following the acquisition of substantially all of the global biosimilar...















